8601 - 8650 of 8808 Results
Title
Year
-
OPENTitle: Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-outJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcz052Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/1/fcz052/33640016/fcz052.pdfCitation Count: 28
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://hdl.handle.net/2027.42/137619Citation Count: 93
-
OPENTitle: Therapeutic potential of autophagy-enhancing agents in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0154-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0154-3Citation Count: 266
-
OPENTitle: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page: 1295End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 61
-
OPENTitle: CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiologyJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adu0726Best OA location URL: https://doi.org/10.1126/sciadv.adu0726Citation Count: 0
-
RESTRICTEDTitle: A validation study of the Clinician's Tardive Inventory (CTI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107812End Page: 107812Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107812Citation Count: 0
-
OPENTitle: Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1028End Page: 1039Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28934Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28934Citation Count: 25
-
OPENTitle: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00604-yBest OA location URL: https://www.nature.com/articles/s41531-023-00604-y.pdfCitation Count: 38
-
OPENTitle: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 1016End Page: 1020Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27385Best OA location URL: http://hdl.handle.net/11380/1205920Citation Count: 37
-
OPENTitle: Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric formJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 106Issue #:Start Page: 191End Page: 204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.07.007Best OA location URL: https://doaj.org/article/416c1a4af85442e1a86a6af150c46583Citation Count: 33
-
OPENTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://doi.org/10.1021/acscentsci.8b00879Citation Count: 146
-
OPENTitle: Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligenceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 21End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01318-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-022-01318-7Citation Count: 16
-
OPENTitle: Validating Differential Volatilome Profiles in Parkinson’s DiseaseJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 2Start Page: 300End Page: 306Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.0c01028Best OA location URL: https://doi.org/10.1021/acscentsci.0c01028Citation Count: 36
-
OPENTitle: Optical Structural Analysis of Individual α‐Synuclein OligomersJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 57Issue #: 18Start Page: 4886End Page: 4890Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/anie.201710779Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.201710779Citation Count: 42
-
OPENTitle: High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.70367Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.70367Citation Count: 0
- Characteristics of hospitalized patients with restless legs syndrome in Hawaiʻi by race/ethnicity2025RESTRICTEDTitle: Characteristics of hospitalized patients with restless legs syndrome in Hawaiʻi by race/ethnicityJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108038End Page: 108038Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108038Citation Count: 0
-
OPENTitle: Orthogonal analysis of mitochondrial function in Parkinson’s disease patientsJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06617-6Best OA location URL: https://www.nature.com/articles/s41419-024-06617-6.pdfCitation Count: 8
-
RESTRICTEDTitle: Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107853End Page: 107853Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107853Citation Count: 0
-
OPENTitle: Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosisJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 27Issue #: 21Start Page: 3761End Page: 3771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddy260Best OA location URL: https://academic.oup.com/hmg/article-pdf/27/21/3761/26127115/ddy260.pdfCitation Count: 53
-
OPENTitle: Neonatal mitochondrial abnormalities due to PINK1 deficiency: Proteomics reveals early changes relevant to Parkinson׳s diseaseJournal Name: Data in BriefPublisher: Elsevier BVVol: 6Issue #:Start Page: 428End Page: 432Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.dib.2015.11.070Best OA location URL: https://doi.org/10.1016/j.dib.2015.11.070Citation Count: 8
-
OPENTitle: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophagesJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 8Issue #: 2Start Page: e001617End Page: e001617Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1136/jitc-2020-001617Best OA location URL: https://jitc.bmj.com/content/jitc/8/2/e001617.full.pdfCitation Count: 44
-
OPENTitle: Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by GlucosylceramideJournal Name: NeuronPublisher: Elsevier BVVol: 97Issue #: 1Start Page: 92End Page: 107.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.12.012Best OA location URL: http://www.cell.com/article/S0896627317311352/pdfCitation Count: 195
-
OPENTitle: C9orf72-G4C2 Intermediate Repeats and Parkinson’s Disease; A Data-Driven HypothesisJournal Name: GenesPublisher: MDPI AGVol: 12Issue #: 8Start Page: 1210End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes12081210Best OA location URL: https://www.mdpi.com/2073-4425/12/8/1210/pdf?version=1628215581Citation Count: 3
-
RESTRICTEDTitle: Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 18End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.03.017Best OA location URL: https://www.osti.gov/biblio/1601044Citation Count: 66
-
OPENTitle: More of less: Novel multi-ome profiling of single human neuronsJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 2Issue #: 3Start Page: 100110End Page: 100110Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2022.100110Best OA location URL: https://doi.org/10.1016/j.xgen.2022.100110Citation Count: 0
-
OPENTitle: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 17Start Page: 13435End Page: 13435Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241713435Best OA location URL: https://www.mdpi.com/1422-0067/24/17/13435/pdf?version=1693464631Citation Count: 4
-
RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Best OA location URL: https://hdl.handle.net/11584/325357Citation Count: 19
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 113
-
RESTRICTEDTitle: Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 124Issue #:Start Page: 130259End Page: 130259Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2025.130259Citation Count: 0
-
OPENTitle: Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00763-6Best OA location URL: https://www.nature.com/articles/s41531-024-00763-6.pdfCitation Count: 12
-
OPENTitle: Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s DiseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 22Issue #: 4Start Page: 930End Page: 940Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.12.092Best OA location URL: http://www.cell.com/article/S2211124717319290/pdfCitation Count: 456
-
OPENTitle: Subcortical grey matter changes associated with motor symptoms evaluated by the Unified Parkinson’s disease Rating Scale (part III): A longitudinal study in Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 31Issue #:Start Page: 102745End Page: 102745Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2021.102745Best OA location URL: https://doi.org/10.1016/j.nicl.2021.102745Citation Count: 12
-
OPENTitle: Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medicationsJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 119Issue #:Start Page: 24End Page: 33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2018.07.024Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2018.07.024Citation Count: 17
-
RESTRICTEDTitle: The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian ratsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 545Issue #:Start Page: 59End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.04.017Citation Count: 7
-
OPENTitle: Immunotherapy in Parkinson’s disease: Current status and future directionsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104587End Page: 104587Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104587Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104587Citation Count: 66
-
OPENTitle: Cerebellum mitochondrial DNA copy number is increased in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 4Start Page: fcaf296End Page: fcaf296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf296Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf296/64085391/fcaf296.pdfCitation Count: 0
-
OPENTitle: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamineJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3Best OA location URL: https://doi.org/10.1096/fasebj.31.1_supplement.987.3Citation Count: 3
-
OPENTitle: Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is PresentJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 157End Page: 160Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20159Best OA location URL: https://doi.org/10.14802/jmd.20159Citation Count: 10
-
OPENTitle: Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the BrainJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 4Issue #: 7Start Page: 788End Page: 795Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.5b00040Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4547530Citation Count: 29
-
OPENTitle: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled ImagesJournal Name: CellPublisher: Elsevier BVVol: 173Issue #: 3Start Page: 792End Page: 803.e19Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040Best OA location URL: http://www.cell.com/article/S0092867418303647/pdfCitation Count: 609
-
OPENTitle: Pre-symptomatic Parkinson’s disease blood test quantifying repetitive sequence motifs in transfer RNA fragmentsJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s43587-025-00851-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12092246Citation Count: 3
-
OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 503End Page: 512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25824Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7719613Citation Count: 109
-
RESTRICTEDTitle: Thalamic deep brain stimulation for drug-induced tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 11Start Page: 1369End Page: 1370Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.033Citation Count: 7
-
OPENTitle: The In Situ Structure of Parkinson’s Disease-Linked LRRK2Journal Name: CellPublisher: Elsevier BVVol: 182Issue #: 6Start Page: 1508End Page: 1518.e16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2020.08.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7869717Citation Count: 192
-
RESTRICTEDTitle: 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated miceJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 92Issue #:Start Page: 86End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2014.11.005Citation Count: 59
-
OPENTitle: Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's diseaseJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 133Issue #: 6Start Page: 451End Page: 458Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12483Best OA location URL: http://www.scopus.com/inward/record.url?scp=84941312569&partnerID=8YFLogxKCitation Count: 26
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 17
-
OPENTitle: Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom OnsetJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 3Start Page: 207End Page: 207Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13030207Best OA location URL: https://www.mdpi.com/2073-4409/13/3/207/pdf?version=1706001350Citation Count: 2
-
OPENTitle: Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 25Issue #: 4Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.10-173625Citation Count: 129
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4